Stay updated on Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page.
Latest updates to the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.1%
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check29 days agoNo Change Detected
- Check44 days agoChange DetectedThe study has been updated to version v2.10.0, replacing the previous version v2.9.7.SummaryDifference0.3%
- Check51 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check65 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.SummaryDifference0.1%
- Check70 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page.